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Lou Gehrig's diseaseCu/Zn-superoxide dismutase (SOD1) is present in the cytosol, nucleus, peroxisomes and mitochondrial
intermembrane space of human cells. More than 114 variants of human SOD1 have been linked to familial
amyotrophic lateral sclerosis (ALS), which is also known as Lou Gehrig's disease. Although the ultimate
mechanisms underlying SOD1-mediated cytotoxicity are largely unknown, SOD1 aggregates have been strongly
implicatedas a common feature inALS. This studyexamined themechanism for the formationof SOD1aggregates
in vitro aswell as thenature of its cytotoxicity. The aggregationpropensity of SOD1specieswas investigatedusing
techniques ranging from circular dichroism spectroscopy to ﬂuorescence dye binding methods, as well as
electron microscopic imaging. The aggregation of SOD1 appears to be related to its structural instability. The
demetallated (apo)-SOD1 and aggregated SOD1 species, with structurally disordered regions, readily undergo
aggregation in the presence of lipid molecules, whereas metallated (holo)-SOD1 does not. The majority of
aggregated SOD1s that are induced by lipid molecules have an amorphous morphology and exhibit signiﬁcant
cytotoxicity. The lipid binding propensity of SOD1 was found to be closely related to the changes in surface
hydrophobicity of the proteins, even at very low levels, which induced further binding and assembly with lipid
molecules. These ﬁndings suggest that lipid molecules induce SOD1 aggregation under physiological conditions
and exert cytotoxicity, and might provide a possible mechanism for the pathogenesis of ALS.82 2 885 6670.
l rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Cu/Zn superoxide dismutase (SOD1) [1], a 32 kDa homodimeric
protein comprised of two identical subunits arranged in eight β-strands
connected by seven loops, is found in the cytosol, nucleus, peroxisomes,
lysosomes, andmitochondrial intermembrane space of eukaryotic cells.
It functions primarily as an antioxidant enzyme to reduce the steady-
state concentration of superoxide anions. However, structural disorders
in SOD1, such as mutations and aggregation, have been linked to the
development of familial amyotrophic lateral sclerosis (ALS). ALS is a
progressive, fatal neurodegenerative disease that mainly affects the
motor neurons in the brain stem and spinal cord. Recent studies have
shown that SOD1aggregates are present in the tissues fromALSpatients
[2,3], ALS-SOD1 transgenic mice [4,5], as well as in cell culture models,
which indicates that SOD1-associated familial ALS is a protein
conformational disorder that is similar to other neurodegenerative
diseases in which protein aggregates play a role [6]. Although the
ultimate mechanisms underlying SOD1-mediated cytotoxicity areunknown, SOD1aggregates havebeen strongly implicated as a causative
factor in the disease. Many experimental studies have attempted to
deﬁne the critical factors leading to SOD1 aggregation because the
aggregation of SOD1 is a complex multistep process consisting of dimer
dissociation, loss of metals, conformational changes, nucleation and
accretion, and involves a variety of cellular components [7,8]. In this
regard, it is generally accepted that altering thephysiological conditions,
such as increasing the temperature, lowering the pH, adding a metal
chelator, reduction of disulﬁde linkages, and oxidativemodiﬁcation, can
affect the formation of SOD1 aggregates [8–11]. Recently, the formation
of SOD1 aggregates as a result of interactions with other cellular
components was also suggested [12,13]. Considering the ubiquitous
distribution of SOD1 in a cell (i.e. cytosol, nucleus, peroxisomes,
lysosomes, and mitochondrial intermembrane space), it would not be
surprising that aberrant SOD1 species can interact with other cellular
components, which may eventually be involved in the formation of
heterogeneous aggregates without perturbing physiological conditions.
In this study, we examined the in vitro SOD1 aggregation in the
presence of lipid molecules as a possible aggregation model system for
ALS. Lipid molecules serve as mediators for signaling and inﬂammation
during the progression of neurodegeneration. Although SOD1 is
frequently in contact with lipids, the interactions with SOD1 have not
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[14–16]. The lipid molecule-associated behavior of proteins can be
generally derived from interactions between the lipid molecules and
proteins, and the extent of these interactions would be expected to
promote the lipid molecule mediated abnormal assembly of SOD1.
These ﬁndings suggest that lipid molecules promote the abnormal
assembly and cytotoxic aggregation of SOD1. This aggregation was
found to be strongly related to the structural instability and afﬁnity of
SOD1 for binding to lipid molecules. These results show that lipid
molecules, acting as a promoter, lead to a signiﬁcant acceleration of
SOD1 aggregation, as evidenced by ﬂuorescence dye binding and the
negatively stained electron micrographs. The cytotoxicity of the
resulting aggregates was also evaluated through cellular viability
measurements.
2. Materials and methods
2.1. Chemicals
Bovine serum albumin (BSA), DPPC (1,2-dipalmitoyl-sn-glycero-3-
Phosphocholine), POPC (1-palmitoyl-2-oleoyl-phosphatidylcholine),
cholesterol, Thioﬂavin-T (ThT) and 8-Anilino-1-naphthalene-sulfonic
acid (ANS) were purchased from Sigma Chemical Co. 2,2,2-triﬂuor-
oethanaol (TFE) was supplied by Aldrich Chemical Co. All chemicals
were used as received without further puriﬁcation. All water was
puriﬁed using a Milli-Q water system (18 MΩ, Millipore).
2.2. Puriﬁcation of SOD1
The proteinswere prepared using the puriﬁcation protocol reported
elsewhere [17–20]. Human SOD1 genes encoding thewild type enzyme
were cloned into the pET23b(+) (Novagen) vector and the proteins
were expressed in E. coli. The cultures were induced by the addition of
0.5 mM isoprophyl b-D-thiogalactopyranoside for 3 to 6 h at 30 °C. The
cells were then lysed by sonication in a buffer containing 150 mMNaCl,
50 mMTris-HCl (pH 8.0), 0.1 mMEDTA, 1 mMdithiothreitol (DTT), and
1 mMphenylmethylsulfonyl ﬂuoride (PMSF). The proteins were eluted
with a linear gradient of ammonium sulfate (0.75–0 M) in 50 mM
sodium phosphate (pH 7.0), 150 mMNaCl, 0.1 mM EDTA and 0.25 mM
DTT. Wild type (WT) SOD1 was released with high speciﬁcity from the
column between 1.3 and 0.8 M ammonium sulfate. Apo type SOD1 was
produced by the demetallation of Zn and Cu.
For the pre-formation of SOD1 aggregates, puriﬁed WT apo SOD1
molecules were dissolved in acidic phosphate buffered saline (PBS)
solution (pH 5.4) at a concentration of 0.1 mg/ml, followed by
the previously reported protocol with a solution containing 20% (v/v)
TFE [21].
2.3. Preparation of lipid vesicles
To prepare all lipid vesicles, a 40 mg of lipids was dissolved in 4 mL
chloroform in a small vial, agitated and exposed to three freeze-thaw
cycles using liquid nitrogen. The organic solvent was evaporated with a
N2 stream, leaving a thin lipid layer on the inner wall of the vial. The
dried lipid ﬁlms were resuspended in a 25 mMPBS solution (pH 7.0) at
a concentration of 0.1 mg/mL. The suspension was sonicated at
low amplitude in an ice bath for 30 min. Sonication was carried out at
5-minute intervals to avoid an excessive increase in suspension
temperature. The resulting vesicle solution was stored at 4 °C for 1 h
prior to use.
2.4. Incubation of proteins with lipid vesicles
To determine the effect of the interaction of lipid molecules with
SOD1 on aggregation, SOD1 was incubated with the DPPC (a neutral,
saturated lipid) vesicles in PBS at 37.5 °C. The proteins, apo SOD1, holoSOD1, SOD1 aggregates and BSA, were dissolved in 25 mM PBS at a
concentration of 0.1 mg/ml and added to the vesicle solution to yield
incubation mixtures with a SOD1 to lipid molar ratio of 1:45. As
controls, proteins without DPPC vesicles were also incubated under
the same conditions at 37.5 °C. All samples were incubated without
agitation. At each time point, an aliquot of each sample was taken and
the presence of aggregates was determined using the analytical
methods described below. To further understand the relevance of
lipid molecule-promoted SOD1 aggregation, the above mentioned
procedures were also performed with POPC (a neutral, unsaturated
lipid molecules) vesicles and lipid vesicles containing cholesterols.
2.5. Circular dichroism spectroscopy
The secondary structures of the proteins were examined by
circular dichroism (CD) spectroscopy (Jasco J-715 spectropolarimeter,
USA) equipped with a Naslab temperature controller. A 0.1-cm quartz
cell was used for themeasurements and the CD spectra were recorded
from 190 to 250 nm. All CD measurements were carried out using the
following parameters: 1 nm bandwidth, 50 nm/min run speed, 1 nm
step size, 8.3 s response time and an average of three runs.
2.6. Fluorescence spectroscopy
To monitor the formation of SOD1 aggregates, the ThT ﬂuores-
cence of the incubated samples was measured by ﬂuorescence
spectroscopy (LS 55, PerkinElmer, UK). ThT is associated rapidly
with aggregated structures, giving rise to a new excitation maximum
at approximately 450 nm and enhanced emission at around 482 nm.
Therefore, previous studies employed the ThT binding characteristics
to identify the aggregation propensity of SOD1 [9,21,22]. At each time
point, 150 μL of each sample was mixed with 15 mL of 10 μM ThT in
PBS, and the ﬂuorescence emission intensity was determined at least
3 times for each sample.
ANS ﬂuorescence [12,23] was used to determine the surface
hydrophobicity of the protein. The ANS ﬂuorophore (ﬁnal concentra-
tion 20 μM) was incubated at 37 °C with the proteins in 25 mM PBS.
After excitation at 360 nm, the emission spectra were recorded
between 400 and 700 nm.
2.7. Transmission electron microscopy
Transmission electron microscopy (TEM) was used to characterize
the morphology of the resulting SOD1 aggregates. The samples
(150 μL aliquots) were incubated overnight on 400-mesh carbon-
coated formvar copper grids. The grids were air-dried and stained
with a 1% (wt/vol) solution of uranyl acetate. Specimens were viewed
using a LIBRA energy-ﬁltering transmission electron microscope at an
accelerating voltage of 120 kV. The images were digitized using a
Gatan slow-scan CCD camera and analyzed using a Gatan Pigtal
micrograph.
2.8. Cell culture and toxicity assay
The cytotoxicity of the prepared protein samples was measured
using a simple cell viability assay. The PC-12 cell line, which was
derived from Rattus norvegicus pheochromocytoma (KCLB No,
21721), was obtained from the Korean Cell Line Bank (http://
cellbank.snu.ac.kr). The PC-12 cells were grown in RPMI-1640
media supplemented with 10% fetal bovine serum and 1% antibiotics
in a humidiﬁed atmosphere containing 5% CO2 at 37 °C. The cells were
cultured on poly-L-Lysine coated plates and slides.
The cell viability was determined by a MTT assay for the
mitochondrial function, which is based on the conversion of a
tetrazolium salt into an insoluble formazan product by various
dehydrogenases in the mitochondria. The cells were plated at
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the prepared protein samples for 24 h. At the end of incubation, the cells
were treated with the MTT solution for 30 min at 37 °C in a cell culture
incubator. The resulting blue–colored formazan product was dissolved
in 1 ml of acidiﬁed isopropanol, and the absorbance was measured at
570 nmusingaVersaMax tunableMicroplate reader (MolecularDevices
Corporation, USA).
3. Results
3.1. Structural instability of metal-free SOD1
The propensity of a native protein to undergo aggregation is a
complex property that involves a range of biophysical and physico-
chemical parameters, including the net charge, surface hydrophobic-
ity, and intrinsic secondary structure [24]. Therefore, aggregated
SOD1 species would be expected to have different structural and
physicochemical properties from proteins in the native state. Before
measuring the interactions between the SOD1 and lipid molecules,
the structural and superﬁcial properties of SOD1s were examined
under different conditions by CD spectroscopy and ANS ﬂuorescence
spectroscopy.
Fig. 1A shows the CD pattern for fully metallated (holo) SOD1 (①),
which shows the characteristic peak for an abundant β-sheet
structure. Note that the secondary structure of holo SOD1 is
comprised mainly of 60% β-sheets and 30% random coils with the
remainder being α-helixes [25]. On the other hand, the spectrum of
apo SOD1 (②) shows a broad characteristic peak due to the structural
changes caused by the absence of Cu2+ and Zn2+, which play a role inFig. 1. Structural and superﬁcial properties of the proteins. (A) secondary structures of
the proteins characterized by CD spectra. (B) surface hydrophobicity of the proteins
measured by ANS ﬂuorescence: freshly prepared holo SOD1 ( ), Freshly prepared apo
SOD1 ( ), Apo SOD1 long-timely incubated under a physiological condition ( ), and
SOD1 aggregates prepared by treatment with TFE under acidic conditions (●).the catalytic and structural cores of SOD1, respectively. The structure
of SOD1 becomes ordered as a result of Cu2+ and Zn2+ coordination
[1]. Importantly, these disordered regions as a result of the metal-free
state of SOD1 have been shown to be involved in initiating protein
aggregation, and in some cases, are believed to become integrated
into the aggregate core [8,24,26]. This is also supported by observa-
tions of apo SOD1 species that had been incubated for 2 months at
room temperature. In this case, the characteristic CD patterns (③)
were broadened compared to the patterns of the freshly prepared apo
SOD1. The characteristic pattern of SOD1 totally disappeared (④)
under more severe conditions, such as treatment with TFE (an
aggregation-enhancing agent) [18,21]. Apo SOD1 species readily
assemble into largely aggregated structures under destabilizing
conditions [8,9,13,21]. The CD spectra clearly show the structural
changes in SOD1 during the aggregation progress. In a previous study
[18], the unique secondary structures of native state SOD1 were lost
within 2 days under the TFE treatment conditions. These conforma-
tional changes in the case of the metal-deﬁcient state and/or other
destabilizing conditions are generally accompanied by changes in the
superﬁcial properties of the proteins, e.g. hydrophobicity. The ANS
ﬂuorescence results (Fig. 1B) are consistent with the hydrophobic
residues being exposed as the result of conformational changes
because the ANS dye is a probe for identifying the extent of exposed
hydrophobic surfaces. As shown in Fig. 1B, holo SOD1 did not show
any signiﬁcant ANS ﬂuorescence enhancement from the base line for a
control sample (ANS dye only), whereas substantial ANS ﬂuorescence
enhancement was observed for apo SOD1. This can be attributed to a
conformational change due to the removal of metal ions from its
structure, and is in good agreement with data that appeared in a
previous report [27]. Moreover, the ANS ﬂuorescence enhancements
were more prominent in the case of lengthy incubation (2 months)
and a TFE treatment of apo SOD1. Obviously, this enhancement is
caused by conformational changes in SOD1, resulting in the exposure
of more hydrophobic residues at the surfaces during the aggregation
process.
3.2. Time-resolved analysis of lipid molecule-induced SOD1 aggregation
Three types of SOD1 variants, apo SOD1, holo SOD1 and as-
prepared SOD1 aggregate, were incubated with DPPC lipid vesicles to
examine the lipid molecule-induced aggregation propensity of SOD1.
As a control protein, BSA, which contains abundant α-helixes unlike
SOD1, was also examined. DPPCs are neutral, saturated lipid
molecules that are relatively unreactive compared to other types of
lipid molecules (i.e. cationic, anionic and/or unsaturated lipid
molecules). For example, the electrostatic interactions between
proteins and lipid molecules are also involved in protein aggregation
because the net charge of the protein can be altered by conformational
changes [24,28]. However, the charge of lipid molecules is not a
shared property for all types of lipid molecules. Although many other
parameters can affect interactions between proteins and lipid
molecules [28,29], in this study, we focused on the examining
whether lipid molecule-induced protein aggregation can be induced
by the general nature of lipid molecules, i.e., amphiphilicity. After
incubation with DPPC lipid vesicles, the aggregated SOD1 was
sampled and then subjected to ThT ﬂuorescence measurements. ThT
[9,21,22] is a ﬂuorescence probe used to detect the presence of
aggregates and the amount of aggregated proteins, compared to the
initial state of each sample (Supplement, Fig. S1). Fig. 2A shows the
results for time-resolved analysis of the process of SOD1 aggregation.
Apo SOD1 and an as-prepared SOD1 aggregate, when incubated with
lipidmolecules, showed a higher propensity for aggregation than holo
SOD1 or BSA depending on the incubation time. Native holo SOD1 and
BSA, which are the stable forms, did not show any signiﬁcant changes
in ﬂuorescence intensity. This suggests that they interact minimally or
not at all with lipid molecules. In the case of apo SOD1, which is the
Fig. 2. Time-resolved ThT ﬂuorescence measurement of the samples. (A) The data set
displayed as a function of the incubation time. (◆) SOD1 aggregates incubated with
lipid vesicles, (●) Apo SOD1 incubated with lipid vesicles, ( ) Holo SOD1 incubated
with lipid vesicles, ( ) BSA incubated with lipid vesicles, ( ) SOD1 aggregate, ( ) Apo
SOD, ( ) Holo SOD1, and ( ) BSA. (B) ThT ﬂuorescence enhancement of each sample
after 5 days incubation.
Fig. 3. ANS ﬂuorescence measurement for changes in hydrophobicity during lipid
molecule-induced SOD1 aggregation: Incubation without lipid (white box) and
incubation with lipid molecules (gray box). A plot for a control sample shows the
intrinsic ﬂuorescence of ANS dye (without lipid) and ANS ﬂuorescence of lipid
molecules (with lipid), respectively.
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increase in ﬂuorescence intensity was observed during incubation.
Similarly, a signiﬁcant increase in ﬂuorescence intensity was also
observed for an as prepared SOD1 aggregate. Based on control
measurements, lipid molecules also have a propensity to bind to ThT;
however, no signiﬁcant change in the time-resolved ﬂuorescent
intensities was observed (Supplement, Fig. S2). Therefore, the
addition of lipid molecules to all protein samples generally induced
an increase in ThT ﬂuorescent intensities in the initial state (0 day).
However, the magnitude of the increase was not the same for all
samples. Thus, the initial large increase for an aggregated SOD1 can be
attributed to a rapid association between aggregated SOD1 and lipid
molecules. These results suggest that the conformational changes in
SOD1s, which are observed in apo SOD1 and its aggregate, can
promote further aggregation by assembling with lipid molecules. The
propensity of lipid molecule-induced aggregation was readily con-
ﬁrmed by the enhanced ThT ﬂuorescence intensity after 5 days
incubation (Fig. 2B).
3.3. Changes in hydrophobicity during lipid molecule-induced SOD1
aggregation
The hydrophobicity of SOD1 aggregates assembled with lipid
molecules might be altered to some degree owing to their amphiphi-licity, which is a unique property of lipid molecules. The hydropho-
bicity of the prepared samples was measured to obtain clear evidence
of an assembly with lipid molecules. After incubation for 5 days,
changes in ANS ﬂuorescence intensities were observed before and
after incubation with lipid molecules, as shown in Fig. 3. A plot for a
control sample shows the intrinsic ﬂuorescence of ANS dye (without
lipid) and ANS ﬂuorescence of lipid molecules (with lipid), respec-
tively. This result shows that lipid molecules induce an enhancement
in ANS ﬂuorescence. This can be attributed to the adsorption of ANS
dyes to the hydrocarbon chains in lipid molecules [30–32]. Interest-
ingly, apo SOD1s with lower ANS intensities, compared to lipid
molecules, showed enhanced ANS ﬂuorescence, and that of the SOD1
aggregate with higher ANS intensities showed a decrease in intensity
after incubation with the lipid molecules. These slight discrepancies
are not due simply to the co-existence of two components remaining
unassembled in the mixtures considering the protein to lipid molar
ratio of the incubation mixtures, 1:45. Speciﬁcally, it is due to changes
in the surface hydrophobicity of the newly formed structures formed
from the assembly between lipids and proteins. Native holo SOD1 and
BSA, which are the stable forms, did not show any signiﬁcant changes
in ANS ﬂuorescence intensity. Therefore, these changes in ANS
ﬂuorescence intensities can be interpreted as changes in the
hydrophobicity of the proteins caused by further binding and the
formation of assemblies with lipid molecules.
3.4. Morphological analysis of lipid molecule-induced SOD1 aggregates
Negatively stained samples were observed by TEM to visualize the
protein structures and examine the morphology of the resulting
structures. In the case of apo SOD1, which had been incubated in PBS
buffer for 2 weeks, no visible macrostructures, except for a few small
structures, were observed (Fig. 4A). In the case of SOD1 aggregate
(Fig. 4C) prepared by the TFE treatment, some individual aggregates
ranging in size from several hundreds of nanometers were observed
frequently. In particular, apo SOD1, which had been incubated with
lipid molecules, formed large, amorphous network structures
(Fig. 4B). Dramatic growth of these structures (Fig. 4D) was also
observed in the case of the SOD1 aggregate that had been incubated
with lipid molecules. On the other hand, no visible protein aggregates
were observed in the BSA, BSA-lipid, lipid only samples (Supplement,
Fig. S3). The ThT binding propensities for the resulting aggregated
structures were visualized by ﬂuorescence imaging (insets of each
TEM image). The ﬂuorescence images are completely consistent with
the morphological properties revealed from the TEM images. In
particular, large ﬂuorescence spots, observed in the SOD1 aggregate
Fig. 4. TEM images and ThT ﬂuorescence images for the incubated samples. (A) Apo
SOD1 monomer incubated without lipid vesicles. (B) Apo SOD1 incubated with lipid
vesicles. (C) SOD1 aggregate incubated without lipid vesicles. (D) SOD1 aggregates
incubated with lipid vesicles. The scale bar is 100 nm.
Fig. 5. Cellular toxicity of lipid molecule-induced SOD1 aggregates: Incubation without
lipid vesicles (white box) and incubation with lipid vesicles (gray box). The cytotoxicity
was assessed using an MTT reduction assay. The data is expressed as the average
percentage of MTT reduction ±S.D. relative to the cells treated with the medium alone
from 5 wells. *Showing a signiﬁcant decrease in cell viability compared to the other
samples.
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existence of enormous aggregates formed from the further assembly
with lipid molecules.
From the results, it was concluded that favorable interactions
between lipid molecules and denaturated proteins (i.e. apo SOD1 and
as prepared SOD1 aggregate) promotes the lipid molecule-mediated
abnormal assembly of denaturated SOD1s. As a control, all data (Fig. 2
and Supplement, Fig. S4) obtained from structurally ordered holo
SOD1 strongly support this ﬁnding. After incubation of holo-SOD1
with or without lipid vesicles, their structural and superﬁcial
properties did not change, unlike those of apo SOD1 (metal-deﬁcient).3.5. Cellular toxicity of lipid molecule-induced SOD1 aggregates
Having established that SOD1 variants with structurally disor-
dered regions (i.e. apo SOD1 and as prepared SOD1 aggregate) have
stronger afﬁnity to lipid molecules than the native-state-stable
protein forms (i.e., holo SOD1 and BSA) and consequently form larger
protein aggregates assembled with lipid molecules, their cellular
toxicity was examined using a cell viability assay. Aliquots of the
samples that had been incubated in the presence or absence of lipid
molecules were diluted with the culture medium, and added directly
to the cultures of PC-12 cells. PC-12 cells are a cell line originating
from the pheochromocytoma in rats, and are commonly used as a
research model for examining neurodegenerative diseases and spinal
cord injuries [33–35]. After incubation, the toxicity was evaluated
using a MTT assay. As shown in Fig. 5, the SOD1 aggregates incubated
with lipid molecules as well as the SOD1 aggregate themselves are
quite toxic and clearly reduced the cell viability (*). In contrast, no
signiﬁcant decrease in viability was detected when the cells were
exposed to most of the incubated samples containing only proteins
and/or only lipids. They showed a cell viability of more than 80%, as
shown in control samples. However, the aggregates formed from the
incubation of apo SOD1 with lipid signiﬁcantly reduced the cell
viability by up to 55% (*). This suggests that lipid-induced SOD1
aggregates are quite toxic to cells.3.6. Relevance of lipid molecule-induced SOD1 aggregates
To identify the relevance of this lipid molecule-promoted SOD1
aggregation, apo SOD1 was also incubated with POPC, a neutral,
unsaturated lipid molecule. After incubating apo SOD1 with different
lipid vesicles, the amorphousness of the resulting structures was
determined from CD spectra (Fig. 6A). Similarly, the negatively
stained electron micrographs also revealed the presence of large
amorphous networked structures of SOD1 (Fig. 6B). Moreover, we
performed additional analyses for apo SOD1s that have been
incubated with different lipid vesicle compositions, which are
prepared by inserting cholesterol molecules to lipid vesicles, in an
attempt to mimic the raft domains of real cell membranes. Analogous
results, structural variations (Fig. 7A) and resulting amorphous
morphologies (Fig. 7B), were also obtained for these types of lipid
vesicles. This strongly suggests that lipid molecules can promote the
aggregation of SOD1s with abundant hydrophobic parts exposed by
structural disordering, due to the amphiphilic property as a general
feature of lipid molecules. Fig. 8 shows a schematic description of the
molecular mechanism for the lipid molecule-associated SOD1 aggre-
gation. Based on our ﬁndings, it appears that the structurally
disordered SOD1 variants (apo SOD1 and aggregated SOD1) with
abundant hydrophobic regions can be readily inserted to the inner
space of lipid vesicles, disrupt them, and consequently become
assembled with the hydrophobic tails of lipid molecules.
4. Discussion
This study examined a molecular mechanism involving lipid
molecules in the formation of SOD1 aggregates, as well as the
cytotoxicity of these aggregates. In vitro biophysical analyses showed
that apo SOD1 and aggregated SOD1 species, which undergo
conformational changes from their native structure, aggregated
readily in the presence of lipid molecules, even under physiological
conditions. Conformational changes in SOD1s result in an increase in
surface hydrophobicity, which promotes binding to lipid molecules
with amphiphilic properties. This is consistent with results observed
for structurally ordered proteins (i.e., holo SOD1 and BSA), showing
no signiﬁcant formation of lipid-associated aggregates. That is, the
formation of lipid-associated aggregates can be attributed to
differential interactions between lipid molecules and denaturated
(or native) proteins. Therefore, the extent of these interactions
Fig. 6. Apo SOD1s incubated with POPC lipid vesicles. (A) CD spectra: apo SOD1 (open circle) and apo SOD1 incubated with POPC (closed circle). (B) TEM image. The scale bar is
200 nm.
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turated SOD1s.
It is important to note that interactions between proteins and lipid
molecules can be controlled by many factors. G. P. Gorbenko, et al.
reported that these interactions are controlled by not only the general
physicochemical characteristics of a membrane (i.e., its phase state,
bilayer curvature and elasticity, surface charge, and degree of
hydration), but also the exact chemical nature of membrane lipids
(i.e., the extent of acyl chain unsaturation, conformation and
dynamics of lipid head groups and acyl chains, and protein–lipid
selectivity arising from factors such as the hydrophobic matching)
[28]. In addition, the role of lipid rafts in the protein aggregation has
been also emphasized in some proteins [29].
In this regard, we focused on the aggregation induced by the
general nature of lipid molecules, which is shared between all of the
lipids, that is “amphiphilicity”. We concluded that other parameters,
as mentioned above, can also accelerate or decelerate aggregation to
some extent, compared with our present observation results. To
address this, ﬁrst of all, DPPC (a neutral, saturated lipid molecule),
that is relatively inactive compared to other types of lipid molecules,
was selected as a component of model membrane system. Further-Fig. 7. Apo SOD1s incubated under different lipid vesicle compositions. (A) CD spectra: Hol
black symbols indicated the apo SOD1 incubated under different lipid vesicle compositions,
lipid: cholesterol=1: 1 (▲), and lipid: cholesterol=2: 1 (◆). (B) representative TEM image
bar is 500 nm.more, we performed additional analyses with other different types of
lipid vesicles including unsaturated lipids (POPC) and lipid rafts (lipid
vesicles containing cholesterol), in an attempt to identify the
relevance of this lipid molecule-promoted SOD1 aggregation. Similar
results (Figs. 5 and 7), structural variations and resulting amorphous
morphologies, were also observed for these types of lipid vesicles.
These ﬁndings suggest that lipid molecules can promote the
aggregation of SOD1s with abundant hydrophobic parts exposed by
structural disordering, due to their amphiphilic properties as a general
nature of lipid molecules.
Since lipid molecules are the main components of the cellular
membrane, the proposed molecular mechanism of SOD1 aggregation
can be directly associated with the membrane-related behavior of
SOD1s, such as membrane binding and membrane disruption. In
particular, membrane linked SOD1 aggregates can be formed by the
direct binding of SOD1 species to membranes, and/or the assembly of
SOD1 with detached lipid molecules. Consequently, these assembled
macrostructures would be expected to have an effect on cell viability,
for example, homeostasis and permeability [14,36,37]. It has been
extensively reported that interactions between proteins and lipid
molecules may play a crucial role in determining the membrane-o SOD1 (open circle) and apo SOD1 (gray closed circle) are control samples. All closed
which are prepared by insulting cholesterol molecules to lipid vesicles; lipid only (●),
s of resulting structures incubated under different lipid vesicle compositions. The scale
Fig. 8. A schematic description of the lipid molecule-associated SOD1 aggregation.
47I. Choi et al. / Biochimica et Biophysica Acta 1812 (2011) 41–48associated cytotoxicity of many other proteins that have been
implicated in conformational diseases [14–16,36,37].
Recently, the hypothesis that SOD1 variants might aggregate on
mitochondrial membrane surfaces has received support by the
demonstration that SOD1 aggregates are attached to the cytoplasmic
face of themitochondrial membrane in transgenic ALSmice [4,5,24,38].
Interestingly, it has been reported that SOD1 may form pore structures
in membranes [39,40]. Furthermore, we observed abnormal ion
permeability in real cell membranes induced by aggregated SOD1
(Choi. I et al., unpublished data). The ﬁndings reported herein suggest
that an aggregate with abundant hydrophobic parts, induced by
conformational changes, can be readily inserted into the inner space
of a membrane and assembled with the hydrophobic tails of lipid
molecules, in a similarmanner to that described in Fig. 8. That is, defects
within amembrane can be formedby the detachment of lipidmolecules
that are co-assembled with structurally disordered SOD1species. Such
behaviors of lipid membranes provide a plausible explanation for the
abnormal aggregation and resulting cytotoxicity of disordered SOD1
variants. We expect that, given the ﬁndings presented herein, the lipid
molecule-induced aggregation of SOD1 may be one of the possible
mechanisms for the pathogenesis of ALS.
Acknowledgments
This study was supported by a grant (no. R01-2006-000-10239-0)
from the Basic Research Program of the Korea Science & Engineering
and a grant (101-082-032) from the Ministry of Environment as “The
Eco-technopia 21 project”. This research was also supported by the
WCU (World Class University) program through the National
Research Foundation of Korea funded by the Ministry of Education,
Science and Technology (R31-10013). This work was also supported
by a grant (code: 2010K000354, 2010K000353) from the “Center for
Nanostructured Materials Technology” under “21st Century Frontier
R&D Programs” of the Ministry of Education, Science, and Technology,
Korea. T. Kang acknowledges ﬁnancial support from the Sogang
university research grant.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
doi:10.1016/j.bbadis.2010.09.003.
References
[1] J.S. Valentine, P.A. Doucette, S.Z. Potter, Copper–Zinc superoxide dismutase and
amyotrophic lateral sclerosis, Annu. Rev. Biochem. 74 (2005) 563–593.
[2] L.I. Bruijn, M.K. Houseweart, S. Kato, K.L. Anderson, S.D. Anderson, E. Ohama, A.G.
Reaume, R.W. Scott, D.W. Cleveland, Aggregation and motor neuron toxicity of an
ALS-linked SOD1 mutant independent from wild-type SOD1, Science 281 (1998)
1851–1854.
[3] T. Koide, S. Igarashi, K. Kikugawa, R. Nakanoa, T. Inuzuka, M. Yamada, H.
Takahashi, S. Tsuji, Formation of granular cytoplasmic aggregates in COS7 cellsexpressing mutant Cu/Zn superoxide dismutase associated with familial amyo-
trophic lateral sclerosis, Neurosci. Lett. 257 (1998) 29–32.
[4] C.M. Higgins, C. Jung, Z. Xu, ALS-associated mutant SOD1G93A causes mitochon-
drial vacuolation by expansion of the intermembrane space and by involvement
of SOD1 aggregation and peroxisomes, BMC Neurosci. 4 (16) (2003) 1–14.
[5] J. Liu, C. Lillo, P.A. Jonsson, V.C. Vande, C.M. Ward, T.M. Miller, J.R. Subramaniam,
J.D. Rothstein, S. Marklund, P.M. Andersen, T. Brännström, O. Gredal, P.C. Wong,
D.S. Williams, D.W. Cleveland, Toxicity of familial ALS-linked SOD1 mutants from
selective recruitment to spinal mitochondria, Neuron 43 (2004) 5–17.
[6] C.M. Dobson, Protein folding and misfolding, Nature 426 (2003) 884–890.
[7] F. Zhang, H. Zhu, Intracellular conformational alterations of mutant SOD1 and the
implications for fALSassociated SOD1 mutant induced motor neuron cell death,
Biochim. Biophys. Acta 1760 (2006) 404–414.
[8] S.D. Khare, M. Caplow, N.V. Dokholyan, The rate and equilibrium constants for a
multistep reaction sequence for the aggregation of superoxide dismutase in
amyotrophic lateral sclerosis, Proc. Natl Acad. Sci. USA 97 (2004) 12571–12576.
[9] L. Banci, I. Bertini, A. Durazo, S. Girotto, E.B. Gralla, M. Martinelli, J.S. Valentine, M.
Vieru, J.P. Whitelegge, Metal-free superoxide dismutase forms soluble oligomers
under physiological conditions: a possible general mechanism for familial ALS,
Proc. Natl Acad. Sci. USA 104 (2007) 11263–11267.
[10] M. DiDonato, L. Craig, M.E. Huff, M.M. Thayer, R.M.F. Cardoso, C.J. Kassmann, T.P.
Lo, C.K. Bruns, E.T. Powers, J.W. Kelly, E.D. Getzoff, J.A. Tainer, ALS mutants of
human superoxide dismutase form ﬁbrous aggregates via framework destabili-
zation, J. Mol. Biol. 332 (2003) 601–615.
[11] E. Gaggelli, H. Kozlowski, D. Valennsin, G. Valensin, Copper homeostasis and
neurodegenerative disorders (Alzheimer's, Prion, and Parkinson's diseases and
amyotrophic lateral sclerosis), Chem. Rev. 106 (2006) 1995–2044.
[12] W. Jiang, Y. Han, R. Zhou, L. Zhang, C. Liu, DNA is a template for accelerating
the aggregation of copper, zinc superoxide dismutase, Biochemistry 46 (2007)
5911–5923.
[13] Y.-J. Kim, R. Nakatomi, T. Akagi, T. Hashikawa, R. Takahashi, Unsaturated fatty
acids induce cytotoxic aggregate formation of amyotrophic lateral sclerosis-linked
superoxide dismutase 1 mutants, J. Biol. Chem. 280 (2005) 21515–21521.
[14] E.Y. Chi, S.L. Frey, K.Y.C. Lee, Ganglioside GM1-mediated amyloid-beta ﬁbrillogen-
esis and membrane disruption, Biochemistry 46 (2007) 1913–1924.
[15] J. Madine, A.J. Doig, D.A. Middleton, The aggregation and membrane-binding
properties of an α-synuclein peptide fragment, Biochem. Soc. Trans. 32 (2004)
1127–1129.
[16] J. Kazlauskaite, N. Sanghera, I. Sylvester, C. Vénien-Bryan, T.J.T. Pinheiro, Structural
changes of the Prion protein in lipid membranes leading to aggregation and
ﬁbrillization, Biochemistry 42 (2003) 3295–3304.
[17] T. Kang, S. Hong, I. Choi, J.-J. Sung, Y. Kim, J.-S. Hahn, J. Yi, Reversible pH-driven
conformational switching of tethered superoxide dismutase with gold nanopar-
ticle enhanced surface plasmon resonance spectroscopy, J. Am. Chem. Soc. 128
(2006) 12870–12878.
[18] S. Hong, I. Choi, S. Lee, Y.I. Yang, T. Kang, J. Yi, Sensitive and colorimetric detection
of the structural evolution of superoxide dismutase (SOD1) with gold nanopar-
ticles, Anal. Chem. 81 (2009) 1378–1382.
[19] S. Lee, I. Choi, S. Hong, Y.I. Yang, J. Lee, T. Kang, J. Yi, Highly selective detection of
Cu2+, utilizing speciﬁc binding between Cu-demetallated superoxide dismutase 1
and the Cu2+ ion via surface plasmon resonance spectroscopy, Chem. Commun.
(2009) 6171–6173.
[20] J.M. McCord, I. Fridovich, Superoxide dismutase: an enzymic function for
erythrocuprein (hemocuprein), J. Biol. Chem. 244 (1969) 6049–6055.
[21] P.B. Stathopulos, J.A.O. Rumfeldt, G.A. Scholz, R.A. Irani, H.E. Frey, R.A. Hallewell, J.
R. Lepock, E.M. Meiering, Cu/Zn superoxide dismutase mutants associated with
amyotrophic lateral sclerosis show enhanced formation of aggregates in vitro,
Proc. Natl Acad. Sci. USA 100 (2003) 7021–7026.
[22] L. Banci, I. Bertini, M. Boca, S. Girotto, M. Martinelli, J.S. Valentine, M. Vieru, SOD1
and amyotrophic lateral sclerosis: mutations and oligomerization, PLoS ONE 3
(2008) e1677.
[23] A. Tiwari, Z. Xu, L.J. Hayward, Aberrantly increased hydrophobicity shared by
mutants of Cu, Zn-superoxide dismutase in familial amyotrophic lateral sclerosis,
J. Biol. Chem. 280 (2005) 29771–29779.
[24] B.F. Shaw, J.S. Valentine, How do ALS-associated mutations in superoxide dismutase
1 promote aggregation of the protein? Trends Biochem. Sci. 32 (2007) 78–85.
48 I. Choi et al. / Biochimica et Biophysica Acta 1812 (2011) 41–48[25] H. Nagami, N. Yoshimoto, H. Umakoshi, T. Shimanouchi, R. Kuboi, Liposome-
assisted activity of superoxide dismutase under oxidative stress, J. Biosci. Bioeng.
99 (2005) 423–428.
[26] S.M. Lynch, S.A. Boswell, W. Colón, Kinetic stability of Cu/Zn superoxide dismutase
is dependent on its metal ligands: implications for ALS, Biochemistry 43 (2004)
16525–16531.
[27] A. Tiwari, A. Liba, S.H. Sohn, S.V. Seetharaman, O. Bilsel, C.R. Matthews, P.J. Hart, J.S.
Valentine, L.J. Hayward, Metal deﬁciency increases aberrant hydrophobicity of
mutant superoxide dismutases that cause amyotrophic lateral sclerosis, J. Biol.
Chem. 284 (2009) 27746–27758.
[28] G.P. Gorbenko, P.K.J. Kinnunen, The role of lipid–protein interactions in amyloid-
type protein ﬁbril formation, Chem. Phys. Lipids 141 (2006) 72–82.
[29] T.J.T. Pinheiro, The role of rafts in the ﬁbrillization and aggregation of prions,
Chem. Phys. Lipids 141 (2006) 66–71.
[30] F. Conti, F. Malerba, Fluorescence signals in ANS-stained lipid bilayers under
applied potentials, Biophysik 8 (1972) 326–332.
[31] G.L. Jendrasiak, T.N. Estep, The interaction of 1-anilino-8-naphthalenesulfonate
with thyroid lipids and membranes: a nuclear magnetic resonance study, Chem.
Phys. Lipids 19 (1977) 323–337.
[32] H. Merkle, W.K. Subczynski, A. Kusumi, Dynamic ﬂuorescence quenching studies
on lipid mobilities in phosphatidylcholine–cholesterol membranes, Biochim.
Biophys. Acta Biomembranes 897 (1987) 238–248.
[33] K. Seth, A.K. Agrawal, M.H. Aziz, A. Ahmad, Y. Shukla, N. Mathur, P.K. Seth, Induced
expression of early response genes/oxidative injury in rat pheochromocytoma(PC12) cell line by 6-hydroxydopamine: implication for Parkinson's disease,
Neurosci. Lett. 330 (2002) 89–93.
[34] D.A. Harris, Cellular biology of prion diseases, Clin. Microbiol. Rev. 12 (1999)
429–444.
[35] S.H. Kim, Y. Shi, K.A. Hanson, L.M. Williams, R. Sakasai, M.J. Bowler, R.S. Tibbetts,
Potentiation of amyotrophic lateral sclerosis (ALS)-associated TDP-43 aggrega-
tion by the proteasome-targeting factor, ubiquilin 1, J. Biol. Chem. 284 (2009)
8083–8092.
[36] M.F.M. Engel, L. Khemtémourian, C.C. Kleijer, H.J.D. Meeldijk, J. Jacobs, A.J. Verkleij,
B. Kruijff, J.A. Killian, J.W.M. Höppener, Membrane damage by human islet
amyloid polypeptide through ﬁbril growth at the membrane, Proc. Natl Acad. Sci.
USA 105 (2008) 6033–6038.
[37] R. Friedman, R. Pellarin, A. Caﬂisch, Amyloid aggregation on lipid bilayers and its
impact on membrane permeability, J. Mol. Biol. 387 (2009) 407–415.
[38] J. Zhai, A.-L. Ström, R. Kilty, P. Venkatakrishnan, J. White, W.V. Everson, E.J. Smart,
H. Zhu, Proteomic characterization of lipid raft proteins in amyotrophic lateral
sclerosis mouse spinal cord, FEBS J. 276 (2009) 3308–3323.
[39] J. Chung, H. Yang, M.D. de Beus, C.Y. Ryu, K. Cho, W. Colon, Cu/Zn superoxide
dismutase can form pore-like structures, Biochem. Biophys. Res. Commun. 312
(2003) 873–876.
[40] S.S. Ray, R.J. Nowak, K. Strokovich, R.H. Brown Jr., T. Walz, P.T. Lansbury Jr., An
intersubunit disulﬁde bond prevents in vitro aggregation of a superoxide
dismutase-1 mutant linked to familial amytrophic lateral sclerosis, Biochemistry
43 (2004) 4899–4905.
